Atıf İçin Kopyala
Patard J., Pignot G., Escudier B., Eisen T., Bex A., Sternberg C., ...Daha Fazla
EUROPEAN UROLOGY, cilt.60, sa.4, ss.684-690, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
60
Sayı:
4
-
Basım Tarihi:
2011
-
Doi Numarası:
10.1016/j.eururo.2011.06.017
-
Dergi Adı:
EUROPEAN UROLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.684-690
-
Anahtar Kelimeler:
Renal cell carcinoma, First-line, Second-line, Treatment algorithms, VEGF-targeted therapy, mTOR inhibitors, RENAL-CELL CARCINOMA, SORAFENIB PLUS INTERFERON-ALPHA-2B, COMBINATION TARGETED THERAPY, PHASE-II TRIAL, PULMONARY RESECTION, BEVACIZUMAB, SUNITINIB, ALPHA, NEPHRECTOMY, EVEROLIMUS
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Context: Until the development of novel targeted agents directed against angiogenesis and tumour growth, few treatment options have been available for the treatment of metastatic renal-cell carcinoma (mRCC).